Next-Generation Breast Cancer Diagnostic and Screening Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Real-Time PCR (q-PCR)
1.2.3 Immunohistochemistry (IHC)
1.2.4 Next-Generation Sequencing (NGS)
1.2.5 Fluorescent In-Situ Hybridization (FISH)
1.3 Market by Application
1.3.1 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital-associated Labs
1.3.3 Cancer Research Institutes
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Next-Generation Breast Cancer Diagnostic and Screening Market Perspective (2017-2028)
2.2 Next-Generation Breast Cancer Diagnostic and Screening Growth Trends by Region
2.2.1 Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Next-Generation Breast Cancer Diagnostic and Screening Historic Market Size by Region (2017-2022)
2.2.3 Next-Generation Breast Cancer Diagnostic and Screening Forecasted Market Size by Region (2023-2028)
2.3 Next-Generation Breast Cancer Diagnostic and Screening Market Dynamics
2.3.1 Next-Generation Breast Cancer Diagnostic and Screening Industry Trends
2.3.2 Next-Generation Breast Cancer Diagnostic and Screening Market Drivers
2.3.3 Next-Generation Breast Cancer Diagnostic and Screening Market Challenges
2.3.4 Next-Generation Breast Cancer Diagnostic and Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next-Generation Breast Cancer Diagnostic and Screening Players by Revenue
3.1.1 Global Top Next-Generation Breast Cancer Diagnostic and Screening Players by Revenue (2017-2022)
3.1.2 Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Players (2017-2022)
3.2 Global Next-Generation Breast Cancer Diagnostic and Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next-Generation Breast Cancer Diagnostic and Screening Revenue
3.4 Global Next-Generation Breast Cancer Diagnostic and Screening Market Concentration Ratio
3.4.1 Global Next-Generation Breast Cancer Diagnostic and Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Breast Cancer Diagnostic and Screening Revenue in 2021
3.5 Next-Generation Breast Cancer Diagnostic and Screening Key Players Head office and Area Served
3.6 Key Players Next-Generation Breast Cancer Diagnostic and Screening Product Solution and Service
3.7 Date of Enter into Next-Generation Breast Cancer Diagnostic and Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next-Generation Breast Cancer Diagnostic and Screening Breakdown Data by Type
4.1 Global Next-Generation Breast Cancer Diagnostic and Screening Historic Market Size by Type (2017-2022)
4.2 Global Next-Generation Breast Cancer Diagnostic and Screening Forecasted Market Size by Type (2023-2028)
5 Next-Generation Breast Cancer Diagnostic and Screening Breakdown Data by Application
5.1 Global Next-Generation Breast Cancer Diagnostic and Screening Historic Market Size by Application (2017-2022)
5.2 Global Next-Generation Breast Cancer Diagnostic and Screening Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Next-Generation Breast Cancer Diagnostic and Screening Market Size (2017-2028)
6.2 North America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type
6.2.1 North America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022)
6.2.2 North America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2023-2028)
6.2.3 North America Next-Generation Breast Cancer Diagnostic and Screening Market Share by Type (2017-2028)
6.3 North America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application
6.3.1 North America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022)
6.3.2 North America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2023-2028)
6.3.3 North America Next-Generation Breast Cancer Diagnostic and Screening Market Share by Application (2017-2028)
6.4 North America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country
6.4.1 North America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2017-2022)
6.4.2 North America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size (2017-2028)
7.2 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type
7.2.1 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022)
7.2.2 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2023-2028)
7.2.3 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Share by Type (2017-2028)
7.3 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application
7.3.1 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022)
7.3.2 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2023-2028)
7.3.3 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Share by Application (2017-2028)
7.4 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country
7.4.1 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2017-2022)
7.4.2 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size (2017-2028)
8.2 Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type
8.2.1 Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Share by Type (2017-2028)
8.3 Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application
8.3.1 Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Share by Application (2017-2028)
8.4 Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region
8.4.1 Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size (2017-2028)
9.2 Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type
9.2.1 Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022)
9.2.2 Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2023-2028)
9.2.3 Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Share by Type (2017-2028)
9.3 Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application
9.3.1 Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022)
9.3.2 Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2023-2028)
9.3.3 Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Share by Application (2017-2028)
9.4 Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country
9.4.1 Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2017-2022)
9.4.2 Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size (2017-2028)
10.2 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type
10.2.1 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Share by Type (2017-2028)
10.3 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application
10.3.1 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Share by Application (2017-2028)
10.4 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country
10.4.1 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Introduction
11.1.4 Abbott Laboratories Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 Agendia
11.2.1 Agendia Company Details
11.2.2 Agendia Business Overview
11.2.3 Agendia Next-Generation Breast Cancer Diagnostic and Screening Introduction
11.2.4 Agendia Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
11.2.5 Agendia Recent Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Introduction
11.3.4 Agilent Technologies Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
11.3.5 Agilent Technologies Recent Developments
11.4 Ambry Genetics
11.4.1 Ambry Genetics Company Details
11.4.2 Ambry Genetics Business Overview
11.4.3 Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Introduction
11.4.4 Ambry Genetics Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
11.4.5 Ambry Genetics Recent Developments
11.5 Biocept
11.5.1 Biocept Company Details
11.5.2 Biocept Business Overview
11.5.3 Biocept Next-Generation Breast Cancer Diagnostic and Screening Introduction
11.5.4 Biocept Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
11.5.5 Biocept Recent Developments
11.6 Biotheranostics
11.6.1 Biotheranostics Company Details
11.6.2 Biotheranostics Business Overview
11.6.3 Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Introduction
11.6.4 Biotheranostics Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
11.6.5 Biotheranostics Recent Developments
11.7 Centogene
11.7.1 Centogene Company Details
11.7.2 Centogene Business Overview
11.7.3 Centogene Next-Generation Breast Cancer Diagnostic and Screening Introduction
11.7.4 Centogene Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
11.7.5 Centogene Recent Developments
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Details
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Introduction
11.8.4 Danaher Corporation Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
11.8.5 Danaher Corporation Recent Developments
11.9 EXACT Sciences Corporation
11.9.1 EXACT Sciences Corporation Company Details
11.9.2 EXACT Sciences Corporation Business Overview
11.9.3 EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Introduction
11.9.4 EXACT Sciences Corporation Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
11.9.5 EXACT Sciences Corporation Recent Developments
11.10 Roche Holding AG
11.10.1 Roche Holding AG Company Details
11.10.2 Roche Holding AG Business Overview
11.10.3 Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Introduction
11.10.4 Roche Holding AG Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
11.10.5 Roche Holding AG Recent Developments
11.11 Fulgent Genetics
11.11.1 Fulgent Genetics Company Details
11.11.2 Fulgent Genetics Business Overview
11.11.3 Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Introduction
11.11.4 Fulgent Genetics Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
11.11.5 Fulgent Genetics Recent Developments
11.12 Illumina
11.12.1 Illumina Company Details
11.12.2 Illumina Business Overview
11.12.3 Illumina Next-Generation Breast Cancer Diagnostic and Screening Introduction
11.12.4 Illumina Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
11.12.5 Illumina Recent Developments
11.13 Invitae
11.13.1 Invitae Company Details
11.13.2 Invitae Business Overview
11.13.3 Invitae Next-Generation Breast Cancer Diagnostic and Screening Introduction
11.13.4 Invitae Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
11.13.5 Invitae Recent Developments
11.14 Lucence Diagnostics Pte Ltd
11.14.1 Lucence Diagnostics Pte Ltd Company Details
11.14.2 Lucence Diagnostics Pte Ltd Business Overview
11.14.3 Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Introduction
11.14.4 Lucence Diagnostics Pte Ltd Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
11.14.5 Lucence Diagnostics Pte Ltd Recent Developments
11.15 Myriad Genetics
11.15.1 Myriad Genetics Company Details
11.15.2 Myriad Genetics Business Overview
11.15.3 Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Introduction
11.15.4 Myriad Genetics Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
11.15.5 Myriad Genetics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Real-Time PCR (q-PCR)
Table 3. Key Players of Immunohistochemistry (IHC)
Table 4. Key Players of Next-Generation Sequencing (NGS)
Table 5. Key Players of Fluorescent In-Situ Hybridization (FISH)
Table 6. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Next-Generation Breast Cancer Diagnostic and Screening Market Share by Region (2017-2022)
Table 10. Global Next-Generation Breast Cancer Diagnostic and Screening Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Next-Generation Breast Cancer Diagnostic and Screening Market Share by Region (2023-2028)
Table 12. Next-Generation Breast Cancer Diagnostic and Screening Market Trends
Table 13. Next-Generation Breast Cancer Diagnostic and Screening Market Drivers
Table 14. Next-Generation Breast Cancer Diagnostic and Screening Market Challenges
Table 15. Next-Generation Breast Cancer Diagnostic and Screening Market Restraints
Table 16. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Share by Players (2017-2022)
Table 18. Global Top Next-Generation Breast Cancer Diagnostic and Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Breast Cancer Diagnostic and Screening as of 2021)
Table 19. Ranking of Global Top Next-Generation Breast Cancer Diagnostic and Screening Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Next-Generation Breast Cancer Diagnostic and Screening Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Next-Generation Breast Cancer Diagnostic and Screening Product Solution and Service
Table 23. Date of Enter into Next-Generation Breast Cancer Diagnostic and Screening Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Type (2017-2022)
Table 27. Global Next-Generation Breast Cancer Diagnostic and Screening Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Type (2023-2028)
Table 29. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Share by Application (2017-2022)
Table 31. Global Next-Generation Breast Cancer Diagnostic and Screening Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Share by Application (2023-2028)
Table 33. North America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2023-2028) & (US$ Million)
Table 63. Abbott Laboratories Company Details
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Product
Table 66. Abbott Laboratories Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022) & (US$ Million)
Table 67. Abbott Laboratories Recent Developments
Table 68. Agendia Company Details
Table 69. Agendia Business Overview
Table 70. Agendia Next-Generation Breast Cancer Diagnostic and Screening Product
Table 71. Agendia Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022) & (US$ Million)
Table 72. Agendia Recent Developments
Table 73. Agilent Technologies Company Details
Table 74. Agilent Technologies Business Overview
Table 75. Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Product
Table 76. Agilent Technologies Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022) & (US$ Million)
Table 77. Agilent Technologies Recent Developments
Table 78. Ambry Genetics Company Details
Table 79. Ambry Genetics Business Overview
Table 80. Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Product
Table 81. Ambry Genetics Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022) & (US$ Million)
Table 82. Ambry Genetics Recent Developments
Table 83. Biocept Company Details
Table 84. Biocept Business Overview
Table 85. Biocept Next-Generation Breast Cancer Diagnostic and Screening Product
Table 86. Biocept Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022) & (US$ Million)
Table 87. Biocept Recent Developments
Table 88. Biotheranostics Company Details
Table 89. Biotheranostics Business Overview
Table 90. Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Product
Table 91. Biotheranostics Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022) & (US$ Million)
Table 92. Biotheranostics Recent Developments
Table 93. Centogene Company Details
Table 94. Centogene Business Overview
Table 95. Centogene Next-Generation Breast Cancer Diagnostic and Screening Product
Table 96. Centogene Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022) & (US$ Million)
Table 97. Centogene Recent Developments
Table 98. Danaher Corporation Company Details
Table 99. Danaher Corporation Business Overview
Table 100. Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Product
Table 101. Danaher Corporation Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022) & (US$ Million)
Table 102. Danaher Corporation Recent Developments
Table 103. EXACT Sciences Corporation Company Details
Table 104. EXACT Sciences Corporation Business Overview
Table 105. EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Product
Table 106. EXACT Sciences Corporation Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022) & (US$ Million)
Table 107. EXACT Sciences Corporation Recent Developments
Table 108. Roche Holding AG Company Details
Table 109. Roche Holding AG Business Overview
Table 110. Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Product
Table 111. Roche Holding AG Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022) & (US$ Million)
Table 112. Roche Holding AG Recent Developments
Table 113. Fulgent Genetics Company Details
Table 114. Fulgent Genetics Business Overview
Table 115. Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Product
Table 116. Fulgent Genetics Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022) & (US$ Million)
Table 117. Fulgent Genetics Recent Developments
Table 118. Illumina Company Details
Table 119. Illumina Business Overview
Table 120. Illumina Next-Generation Breast Cancer Diagnostic and Screening Product
Table 121. Illumina Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022) & (US$ Million)
Table 122. Illumina Recent Developments
Table 123. Invitae Company Details
Table 124. Invitae Business Overview
Table 125. Invitae Next-Generation Breast Cancer Diagnostic and Screening Product
Table 126. Invitae Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022) & (US$ Million)
Table 127. Invitae Recent Developments
Table 128. Lucence Diagnostics Pte Ltd Company Details
Table 129. Lucence Diagnostics Pte Ltd Business Overview
Table 130. Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Product
Table 131. Lucence Diagnostics Pte Ltd Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022) & (US$ Million)
Table 132. Lucence Diagnostics Pte Ltd Recent Developments
Table 133. Myriad Genetics Company Details
Table 134. Myriad Genetics Business Overview
Table 135. Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Product
Table 136. Myriad Genetics Revenue in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022) & (US$ Million)
Table 137. Myriad Genetics Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next-Generation Breast Cancer Diagnostic and Screening Market Share by Type: 2021 VS 2028
Figure 2. Real-Time PCR (q-PCR) Features
Figure 3. Immunohistochemistry (IHC) Features
Figure 4. Next-Generation Sequencing (NGS) Features
Figure 5. Fluorescent In-Situ Hybridization (FISH) Features
Figure 6. Global Next-Generation Breast Cancer Diagnostic and Screening Market Share by Application: 2021 VS 2028
Figure 7. Hospital-associated Labs Case Studies
Figure 8. Cancer Research Institutes Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Next-Generation Breast Cancer Diagnostic and Screening Report Years Considered
Figure 11. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Next-Generation Breast Cancer Diagnostic and Screening Market Share by Region: 2021 VS 2028
Figure 14. Global Next-Generation Breast Cancer Diagnostic and Screening Market Share by Players in 2021
Figure 15. Global Top Next-Generation Breast Cancer Diagnostic and Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Breast Cancer Diagnostic and Screening as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Next-Generation Breast Cancer Diagnostic and Screening Revenue in 2021
Figure 17. North America Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2017-2028)
Figure 19. North America Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2017-2028)
Figure 20. North America Next-Generation Breast Cancer Diagnostic and Screening Market Size Share by Country (2017-2028)
Figure 21. United States Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2017-2028)
Figure 25. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2017-2028)
Figure 26. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Share by Country (2017-2028)
Figure 27. Germany Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Next-Generation Breast Cancer Diagnostic and Screening Market Size Share by Region (2017-2028)
Figure 37. China Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Next-Generation Breast Cancer Diagnostic and Screening Market Size Share by Country (2017-2028)
Figure 47. Mexico Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Share by Country (2017-2028)
Figure 53. Turkey Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Next-Generation Breast Cancer Diagnostic and Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Abbott Laboratories Revenue Growth Rate in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
Figure 57. Agendia Revenue Growth Rate in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
Figure 58. Agilent Technologies Revenue Growth Rate in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
Figure 59. Ambry Genetics Revenue Growth Rate in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
Figure 60. Biocept Revenue Growth Rate in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
Figure 61. Biotheranostics Revenue Growth Rate in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
Figure 62. Centogene Revenue Growth Rate in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
Figure 63. Danaher Corporation Revenue Growth Rate in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
Figure 64. EXACT Sciences Corporation Revenue Growth Rate in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
Figure 65. Roche Holding AG Revenue Growth Rate in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
Figure 66. Fulgent Genetics Revenue Growth Rate in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
Figure 67. Illumina Revenue Growth Rate in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
Figure 68. Invitae Revenue Growth Rate in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
Figure 69. Lucence Diagnostics Pte Ltd Revenue Growth Rate in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
Figure 70. Myriad Genetics Revenue Growth Rate in Next-Generation Breast Cancer Diagnostic and Screening Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Industry Market Size
